Stock Price Quote

ENTERO HEALTHCARE SOLUTIONS LTD.

NSE : ENTEROBSE : 544122ISIN CODE : INE010601016Industry : TradingHouse : Private
BSE1463.80-4.2 (-0.29 %)
PREV CLOSE ( ) 1468.00
OPEN PRICE ( ) 1473.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1152
TODAY'S LOW / HIGH ( )1447.95 1482.55
52 WK LOW / HIGH ( )974.45 1583
NSE1461.05-11.25 (-0.76 %)
PREV CLOSE( ) 1472.30
OPEN PRICE ( ) 1455.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1461.05 (462)
VOLUME 61595
TODAY'S LOW / HIGH( ) 1446.00 1483.90
52 WK LOW / HIGH ( )970 1584.25
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-01 2018
Management Info
Sujesh Vasudevan - Chairman Prabhat Agrawal - Managing Director
Registered Office

Address Plot No. I-35, Building - B,Industrial Area Phase - I,13/7 Mathura Road,
Faridabad,
Haryana-121003

Phone 0129-4877300

Email info@enterohealthcare.com

Website www.enterohealthcare.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

13Nov Entero Healthcare Solutions enters int
Entero Healthcare Solutions has entered into a binding Memorandum of Und..
13Nov Entero Healthcare Solutions informs a
With reference to Regulation 30 of the SEBI (Listing Obligations and Dis..
13Nov Entero Healthcare enters into MoU for
Entero Healthcare Solutions has entered into a binding Memorandum of Und..
05Oct Entero Healthcare Solutions informs ab
Entero Healthcare Solutions has informed that the exchange has received..
01Oct Entero Healthcare Solutions informs ab
Entero Healthcare Solutions has informed that it enclosed disclosure und..

Financials

in Millions
QTR Sep 24 ANNUAL 24
Net Profit153.29384.4
Gross Profit 202.19 243.65
Operating Profit 227.39554.31
Net Sales 1128.323181.61

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Thacker & Co (BSE)
peergroup  2083.00 (4.05%)
M.Cap ( in Cr)226.57
Kemp & Company (BSE)
peergroup  1749.00 (4.71%)
M.Cap ( in Cr)188.93
Macfos (BSE)
peergroup  1455.45 (5.00%)
M.Cap ( in Cr)1370.57
Manbro Industries (BSE)
peergroup  1261.20 (4.70%)
M.Cap ( in Cr)63.37
Rajesh Power Service (BSE)
peergroup  859.65 (5.00%)
M.Cap ( in Cr)1548.01

Shareholding Pattern

PROMOTERS 52.44%
MUTUAL FUNDS/UTI 5.07%
NON-INSTITUTION 16.01%
FI/BANKS/INSURANCE 0.82%
GOVERNMENT 0%
FII 0%

About Entero Healthcare Solutions Ltd.

Entero Healthcare Solutions Ltd. was incorporated in the year 2018. Its today's share price is 1463.8. Its current market capitalisation stands at Rs 6322.25 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3181.61 Cr and Total Income of Rs.4080.86 Cr. The company's management includes Kevin Rohitbhai Daftary, Sumona Chakraborty, Arun Sadhanandham, Sandhya Sharma, Rajesh Shashikant Dalal, Prem Sethi, Prabhat Agrawal, Sujesh Vasudevan, Jayant Prakash.

It is listed on the BSE with a BSE Code of 544122 , NSE with an NSE Symbol of ENTERO and ISIN of INE010601016. It's Registered office is at Plot No. I-35, Building - B,Industrial Area Phase - I,13/7 Mathura RoadFaridabad-121003, Haryana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are MSKA & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.